JP2019508387A5 - - Google Patents

Download PDF

Info

Publication number
JP2019508387A5
JP2019508387A5 JP2018538156A JP2018538156A JP2019508387A5 JP 2019508387 A5 JP2019508387 A5 JP 2019508387A5 JP 2018538156 A JP2018538156 A JP 2018538156A JP 2018538156 A JP2018538156 A JP 2018538156A JP 2019508387 A5 JP2019508387 A5 JP 2019508387A5
Authority
JP
Japan
Prior art keywords
acid
process according
palladium
platinum
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018538156A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019508387A (ja
JP6812449B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/052050 external-priority patent/WO2017134051A1/en
Publication of JP2019508387A publication Critical patent/JP2019508387A/ja
Publication of JP2019508387A5 publication Critical patent/JP2019508387A5/ja
Application granted granted Critical
Publication of JP6812449B2 publication Critical patent/JP6812449B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018538156A 2016-02-01 2017-01-31 オシメルチニブ(azd9291)またはその塩、および「azd9291アニリン」またはその塩を製造するための向上したプロセス Active JP6812449B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662289390P 2016-02-01 2016-02-01
US62/289,390 2016-02-01
PCT/EP2017/052050 WO2017134051A1 (en) 2016-02-01 2017-01-31 Improved process for the preparation of osimertinib (azd9291) or a salt thereof, and "azd9291 aniline" or a salt thereof

Publications (3)

Publication Number Publication Date
JP2019508387A JP2019508387A (ja) 2019-03-28
JP2019508387A5 true JP2019508387A5 (enExample) 2020-01-30
JP6812449B2 JP6812449B2 (ja) 2021-01-13

Family

ID=57984913

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018538156A Active JP6812449B2 (ja) 2016-02-01 2017-01-31 オシメルチニブ(azd9291)またはその塩、および「azd9291アニリン」またはその塩を製造するための向上したプロセス

Country Status (18)

Country Link
US (1) US11180477B2 (enExample)
EP (1) EP3411038B1 (enExample)
JP (1) JP6812449B2 (enExample)
KR (1) KR102749892B1 (enExample)
CN (1) CN108495632B (enExample)
AR (1) AR107494A1 (enExample)
AU (1) AU2017214243B2 (enExample)
BR (1) BR112018014712B1 (enExample)
CA (1) CA3011809C (enExample)
CO (1) CO2018007008A2 (enExample)
ES (1) ES2834608T3 (enExample)
IL (1) IL260665B (enExample)
MX (1) MX378363B (enExample)
MY (1) MY185367A (enExample)
RU (1) RU2733376C2 (enExample)
TW (1) TWI745345B (enExample)
WO (1) WO2017134051A1 (enExample)
ZA (1) ZA201805790B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3464275B1 (en) 2016-05-26 2024-05-08 Recurium IP Holdings, LLC Egfr inhibitor compounds
CN107556293B (zh) * 2017-09-19 2019-12-03 福建省微生物研究所 一种奥西替尼的合成工艺
WO2021111462A1 (en) * 2019-12-02 2021-06-10 Natco Pharma Limited An improved process for the preparation of osimertinib mesylate
US11780824B2 (en) * 2020-12-16 2023-10-10 Scinopharm Taiwan, Ltd. Process for preparing osimertinib or a salt thereof
JP2024530782A (ja) 2021-09-02 2024-08-23 シントン・ビー.ブイ. オシメルチニブの製造方法
WO2025124936A1 (en) 2023-12-15 2025-06-19 Synthon B.V. A process for making osimertinib

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070401A (en) * 1972-02-19 1978-01-24 Mitsui Toatsu Chemicals Inc. Method for the preparation of a halogenated aromatic amine
ES2654177T3 (es) * 2011-07-27 2018-02-12 Astrazeneca Ab Derivados de 2-(2,4,5-anilino sustituido)pirimidina como moduladores de EGFR útiles para tratar el cáncer
BR112016029662B1 (pt) 2014-06-19 2023-10-24 Takeda Pharmaceutical Company Limited COMPOSTO DE FÓRMULA Bf OU UMA FORMA FARMACEUTICAMENTE ACEITÁVEL DO MESMO, COMPOSIÇÃO FARMACÊUTICA COMPREENDENDO O MESMO E SEU USO
CN104817541B (zh) * 2015-05-11 2017-06-16 苏州东南药业股份有限公司 一种抗肿瘤药物的合成方法

Similar Documents

Publication Publication Date Title
JP2019508387A5 (enExample)
US8242310B2 (en) Processes for the preparation of aminosulfone compounds
CN101253163B (zh) 4-氨基-2-(2,6-二氧哌啶-3-基)异吲哚啉-1,3-二酮化合物的制备方法
JP2009527517A5 (enExample)
JP5426693B2 (ja) アゴメラチンハロゲン化水素複合体及びその製造方法
JP2010505926A5 (enExample)
CN105377819B (zh) 制备苯并咪唑衍生物的方法
JP2014522385A5 (enExample)
RU2018130327A (ru) Улучшенный способ получения осимертиниба (azd9291) или его соли и "анилин-azd9291" или его соли
JP2009536618A5 (enExample)
JP2019504839A5 (enExample)
WO2013121234A1 (en) Process for the preparation of dronedarone by oxidation of a sulphenyl group
JP2020508324A5 (enExample)
JP7232618B2 (ja) アコチアミドの改善された製造方法
JP2021046426A5 (enExample)
JP2015508069A5 (enExample)
JP2018521085A5 (enExample)
CN102863341B (zh) 一种(1r,2s)-2-芳基环丙胺衍生物的化学合成方法
JP2018502164A (ja) インダンアミン誘導体の製法及び新規な合成中間体
JP2017534686A (ja) 1−(2−ハロゲン−エチル)−4−ピぺリジンカルボン酸エチルエステルの製法
CN1112347C (zh) 1-三氟甲基-2-烷基乙烯基苯胺衍生物及其合成
CN105272921A (zh) 一种制备Ceritinib的方法及其中间体化合物
CN108329236B (zh) 一种恩杂鲁胺中间体的制备方法
JP2017514846A5 (enExample)
CN106748725B (zh) 一种4-氯-2-氟-苯丙酸的制备方法